Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
This study has been completed.
Sponsor:
Somaxon Pharmaceuticals
Information provided by:
Somaxon Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00132119
First received: August 17, 2005
Last updated: May 15, 2008
Last verified: May 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2006 |
| Primary Completion Date: | August 2006 (Final data collection date for primary outcome measure) |